uspA1 of Moraxella catarrhalis clinical isolates in Japan and its relationship with adherence to HEp-2 cells

Journal of Medical and Dental Sciences

Volumn 56, Issue 1, 2009, Pages 61-67

  Qiu, Hongli ^a   Kumita, Wakako ^a   Sato, Kenya ^a   Nakajima, Shinichi ^a   Nishiyama, Hiroyuki ^a,b   Saito, Ryoichi ^a,c   Sawabe, Etsuko ^a,d   Ono, Emi ^a,e   Chida, Toshio ^a   Okamura, Noboru ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b SURUGADAI NIHON UNIVERSITY HOSPITAL   (Japan)

^c UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY HOSPITAL   (Japan)

^e Nakano General Hospital   (Japan)

Author keywords

16S rRNA type; Adherence; Moraxella catarrhalis; UspA1

Indexed keywords

ADHESIN; OUTER MEMBRANE PROTEIN; RNA 16S; USPA PROTEIN, MORAXELLA CATARRHALIS;

ARTICLE; BACTERIUM ADHERENCE; BACTERIUM IDENTIFICATION; CHEMISTRY; DNA SEQUENCE; EPITHELIUM CELL; GENETICS; HUMAN; MOLECULAR CLONING; MORAXELLA CATARRHALIS; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADHESINS, BACTERIAL; BACTERIAL ADHESION; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL TYPING TECHNIQUES; CLONING, MOLECULAR; EPITHELIAL CELLS; HUMANS; MORAXELLA (BRANHAMELLA) CATARRHALIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA;

EID: 69349091385     PISSN: 13428810     EISSN: 13428810     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Johnson MA, Drew WL, Roberts M. Branhamella (Neisseria) catarrhalis-a lower respiratory tract pathogen? J Clin Microbiol 1981:13:1066-1069.
2. Barnes PJ. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. J Eur Respir 2003:22:672-688.
3. Boyle FM, Georghiou PR, Tilse MH, et al. Branhamella {Moraxella) catarrhalis: pathogenic significance in respiratory infections. Med J Aust 1991:154:592-596.
4. Catlin BW. Branhamella catarrhalis-an organism gaining respect as a pathogen. Clin Microbiol Rev 1990:3:293-320.
5. Bluestone CD, Stephenson JS, Martin LM. Ten-year review of otitis media pathogens. J Pediatr Infect Dis 1992:1 1:S7-S11.
6. Hager H, Verghese A, Alvarez S, et al. Branhamella catarrhalis respiratory infections. Rev Infect Dis 1987:9:1140-1149.
7. Richards SJ, Greening AP, Enright MC, et al. Outbreak of Moraxella catarrhalis in a respiratory unit. Thorax 1993:48:91-92.
8. Aebi C, Lafontaine ER, Cope LD, et al. Phenotypic effect of isogenic uspA1 and uspA2 mutations on Moraxella catarrhalis 035E. Infect Immun 1998:66:3113-31 19.
9. Hu WG, Chen J, McMichael JC, et al. Functional characteristics of a protective monoclonal antibody against serotype A and C lipooligosaccharides from Moraxella catarrhalis. Infect Immun 2001:69:1358-1363.
10. Hill DJ, Virji M. A novel cell-binding mechanism of Moraxella catarrhalis ubiquitous surface protein UspA: specific targeting of the N-domain of carcinoembryonic antigen-related cell adhesion molecules by UspA 1. Mol Microbiol 2003:48:117-129.
11. Forsgren A, Brant M, Karamehmedovic M, et al. The immunoglobulin D-binding protein MID from Moraxella catarrhalis is also an adhesin. Infect Immun 2003:71:3302-3309.
12. Lafontaine ER, Cope LD, Aebi C, et al. The UspA1 protein and a second type of UspA2 protein mediate adherence of Moraxella catarrhalis to human epithelial cells in vitro. J Bacteriol 2000:182:1364-1373.
13. Reddy MS, Murphy TF, Faden HS, et al. Middle ear mucin glycol protein: purification and interaction with nontypable Haemophilus influenzae and Moraxella catarrhalis. Otolaryngol Head Neck Surg 1997:116:175-180.
14. Holm MM, Vanlerberg SL, Sledjeski DD, et al. The Hag protein of Moraxella catarrhalis strain O35E is associated with adherence to human lung and middle ear cells. Infect Immun 2003:71:4977-4984.
15. McMichael JC, Fiske MJ, Fredenburg RA, et al. Isolation and characterization of two proteins from Moraxella catarrhalis that bear a common epitope. Infect Immun 1998:66:4374-4381.
16. Lafontaine ER, Wagner NJ, Hansen EJ. Expression of the Moraxella catarrhalis UspA1 protein undergoes phase variation and is regulated at the transcriptional level. J Bacteriol 2001:183:1540-1551.
17. Chen D, McMichael JC, Vandermeid KR. Evaluation of purified UspA from Moraxella catarrhalis as a vaccine in a murine model after active immunization. Infect Immun 1996:64:1900-1905.
18. Samukawa T, Yamanaka N, Hollingshead S. Immune responses to specific antigens of Streptococcus pneumoniae and Moraxella catarrhalis in the respiratory tract. Infect Immun 2000:68:1569-1573.
19. Meier PS, Trailer R, Grivea IN, et al. The outer membrane proteins UspA1 and UspA2 of Moraxella catarrhalis are highly conserved in nasopharyngeal isolates from young children. Vaccine 2002:15:1754-1760.
20. Bootsma HJ, Van der Heide HG, Van de Pas S, et al. Analysis of Moraxella catarrhalis by DNA typing: evidence for a distinct subpopulation associated with virulence traits. J Infect Dis 2000:181:1376-1387.
21. Meier PS, Troller R, Heiniger N, et al. Moraxella catarrhalis strains with reduced expression of the UspA outer membrane proteins belong to a distinct subpopulation. Vaccine 2005:23:2000-2008.
22. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y;1989.
23. Slevogt H, Tiwari KN, Schmeck B, et al. Adhesion of Moraxella catarrhalis to human bronchial epithelium characterized by a novel fluorescence-based assay. Med Microbiol Immunol 2006:195:73-83.
24. Aebi C, Maciver I, Latimer JL, et al. A protective epitope of Moraxella catarrhalis is encoded by two different genes. Infect Immun 1997; 65:4367-4377.